These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19243279)

  • 1. Targeting multiple kinases in glioblastoma multiforme.
    Sathornsumetee S; Reardon DA
    Expert Opin Investig Drugs; 2009 Mar; 18(3):277-92. PubMed ID: 19243279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic strategies to target multiple kinases in glioblastoma.
    Sathornsumetee S
    Anticancer Agents Med Chem; 2011 Oct; 11(8):700-11. PubMed ID: 21707500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Protein Kinases for the Treatment of Glioblastoma Multiforme: Linking Basic Studies to Clinical Applications.
    Zhou A
    Curr Pharm Des; 2017 Nov; 23(29):4290-4302. PubMed ID: 28699529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.
    Polivka J; Polivka J; Holubec L; Kubikova T; Priban V; Hes O; Pivovarcikova K; Treskova I
    Anticancer Res; 2017 Jan; 37(1):21-33. PubMed ID: 28011470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant glioma drug discovery - targeting protein kinases.
    Sathornsumetee S; Vredenburgh KA; Lattimore KP; Rich JN
    Expert Opin Drug Discov; 2007 Jan; 2(1):1-17. PubMed ID: 23496034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulated signalling networks in human brain tumours.
    Grzmil M; Hemmings BA
    Biochim Biophys Acta; 2010 Mar; 1804(3):476-83. PubMed ID: 19879382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents.
    Minniti G; Muni R; Lanzetta G; Marchetti P; Enrici RM
    Anticancer Res; 2009 Dec; 29(12):5171-84. PubMed ID: 20044633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The therapeutic potential of Aurora kinases targeting in glioblastoma: from preclinical research to translational oncology.
    de Almeida Magalhães T; de Sousa GR; Alencastro Veiga Cruzeiro G; Tone LG; Valera ET; Borges KS
    J Mol Med (Berl); 2020 Apr; 98(4):495-512. PubMed ID: 32219470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designer therapies for glioblastoma multiforme.
    Sathornsumetee S; Rich JN
    Ann N Y Acad Sci; 2008 Oct; 1142():108-32. PubMed ID: 18990124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the AKT pathway in glioblastoma.
    McDowell KA; Riggins GJ; Gallia GL
    Curr Pharm Des; 2011; 17(23):2411-20. PubMed ID: 21827416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets.
    Mao H; Lebrun DG; Yang J; Zhu VF; Li M
    Cancer Invest; 2012 Jan; 30(1):48-56. PubMed ID: 22236189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HER1/EGFR tyrosine kinase inhibitors for the treatment of glioblastoma multiforme.
    Raizer JJ
    J Neurooncol; 2005 Aug; 74(1):77-86. PubMed ID: 16078112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaplastic Lymphoma Kinase in Glioblastoma: Detection/Diagnostic Methods and Therapeutic Options.
    Kalamatianos T; Denekou D; Stranjalis G; Papadimitriou E
    Recent Pat Anticancer Drug Discov; 2018; 13(2):209-223. PubMed ID: 29336268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of epidermal growth factor receptor and phosphatase and tensin homologue gene expression on the inhibition of U87MG glioblastoma cell proliferation induced by protein kinase inhibitors.
    Xing WJ; Zou Y; Han QL; Dong YC; Deng ZL; Lv XH; Jiang T; Ren H
    Clin Exp Pharmacol Physiol; 2013 Jan; 40(1):13-21. PubMed ID: 23110505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of octamer binding transcription factors in glioblastoma multiforme.
    Rooj AK; Bronisz A; Godlewski J
    Biochim Biophys Acta; 2016 Jun; 1859(6):805-11. PubMed ID: 26968235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving strategies: future treatment of glioblastoma.
    Chamberlain M
    Expert Rev Neurother; 2011 Apr; 11(4):519-32. PubMed ID: 21469925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathways and potential therapeutic targets in glioblastoma multiforme.
    Wardak Z; Choe KS
    Expert Rev Anticancer Ther; 2013 Nov; 13(11):1307-18. PubMed ID: 24168050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting strategies on miRNA-21 and PDCD4 for glioblastoma.
    Wang G; Wang JJ; Tang HM; To SS
    Arch Biochem Biophys; 2015 Aug; 580():64-74. PubMed ID: 26142886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma.
    Li X; Wu C; Chen N; Gu H; Yen A; Cao L; Wang E; Wang L
    Oncotarget; 2016 May; 7(22):33440-50. PubMed ID: 26967052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eph receptors as therapeutic targets in glioblastoma.
    Day BW; Stringer BW; Boyd AW
    Br J Cancer; 2014 Sep; 111(7):1255-61. PubMed ID: 25144626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.